DK0431759T3 - Fremgangsmåde til fremstilling af et ranitidinharpiksadsorbat - Google Patents

Fremgangsmåde til fremstilling af et ranitidinharpiksadsorbat

Info

Publication number
DK0431759T3
DK0431759T3 DK90312263.8T DK90312263T DK0431759T3 DK 0431759 T3 DK0431759 T3 DK 0431759T3 DK 90312263 T DK90312263 T DK 90312263T DK 0431759 T3 DK0431759 T3 DK 0431759T3
Authority
DK
Denmark
Prior art keywords
ranitidine
preparing
resin
adsorbate
resin adsorbate
Prior art date
Application number
DK90312263.8T
Other languages
English (en)
Inventor
Stephen John Douglas
Fiona Ruth Bird
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of DK0431759T3 publication Critical patent/DK0431759T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Phenolic Resins Or Amino Resins (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
  • Glass Compositions (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Furan Compounds (AREA)
DK90312263.8T 1989-11-10 1990-11-09 Fremgangsmåde til fremstilling af et ranitidinharpiksadsorbat DK0431759T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898925484A GB8925484D0 (en) 1989-11-10 1989-11-10 Process

Publications (1)

Publication Number Publication Date
DK0431759T3 true DK0431759T3 (da) 1994-02-28

Family

ID=10666117

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90312263.8T DK0431759T3 (da) 1989-11-10 1990-11-09 Fremgangsmåde til fremstilling af et ranitidinharpiksadsorbat

Country Status (9)

Country Link
EP (1) EP0431759B1 (da)
JP (1) JPH03206037A (da)
AT (1) ATE99925T1 (da)
AU (1) AU6652790A (da)
CA (1) CA2029667A1 (da)
DE (1) DE69005993T2 (da)
DK (1) DK0431759T3 (da)
ES (1) ES2047864T3 (da)
GB (1) GB8925484D0 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9104042D0 (en) * 1991-02-26 1991-04-10 Abbott Lab Taste-masked buflomedil preparation
US20020031490A1 (en) * 2000-07-27 2002-03-14 Bellamy Simon Andrew Method for preparing resinates
CN1615156B (zh) * 2002-01-18 2012-05-30 罗门哈斯公司 制备树脂酸酯的方法
GR1009069B (el) * 2015-01-05 2017-07-07 Λαμδα Φαρμακευτικα Εργαστηρια Εφαρμοσμενης Ερευνας & Αναπτυξης Α.Ε. Ποσιμα διαλυματα υψηλης συγκεντρωσης που περιεχουν υδροχλωρικη ρανιτιδινη

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB838952A (en) * 1957-10-03 1960-06-22 Clinical Products Ltd Resin-drug compounds
FR1335502A (fr) * 1960-06-02 1963-08-23 Merck & Co Inc Nouveaux composés d'adsorption de la nicotinamide
DE2246037B2 (de) * 1972-09-20 1975-02-27 Taeschner & Co, 8831 Kipfenberg Peroral anwendbares Arzneimittel mit verzögerter Resorbierbarkeit in Suspensionsform
GB1462356A (en) * 1973-07-10 1977-01-26 Beecham Group Ltd Pharmaceutical compositions
GB8629781D0 (en) * 1986-12-12 1987-01-21 Glaxo Group Ltd Pharmaceutical compositions
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorption containing ranitidine together with synthetic resin replaces cations, its preparation and pharmaceutical preparations containing it

Also Published As

Publication number Publication date
ATE99925T1 (de) 1994-01-15
DE69005993D1 (de) 1994-02-24
DE69005993T2 (de) 1994-05-05
JPH03206037A (ja) 1991-09-09
EP0431759A1 (en) 1991-06-12
GB8925484D0 (en) 1989-12-28
CA2029667A1 (en) 1991-05-11
ES2047864T3 (es) 1994-03-01
AU6652790A (en) 1991-05-16
EP0431759B1 (en) 1994-01-12

Similar Documents

Publication Publication Date Title
CA2121351A1 (en) The resolution of 5-methyltetrahydrofolic acid
DE69201959D1 (de) Verfahren zur Herstellung von 6,12-Dihydro-6-hydroxy-cannabidiol und dessen Anwendung zur Herstellung von trans-delta-9-Tetrahydrocannabinol.
DE59005902D1 (de) Verfahren zur Herstellung niederer, mehrwertiger Alkohole.
ATE79856T1 (de) Verfahren zur herstellung von dihydroxybenzolen.
DE69007800T2 (de) Verfahren zur fermentativen Herstellung von L-Arginin.
DE58907179D1 (de) Verfahren zur Herstellung von mechanischem Holzstoff und von Papier, das diesen Holzstoff enthält.
EP0391393A3 (de) Verfahren zur Herstellung von Cefodizim-Dinatrium
BE847153A (fr) Procede de preparation d'acide formique pur,
DE68923260T2 (de) Verfahren zur Herstellung eines Derivates der 3,5,6-Trihydroxyhexansäure.
DE59007076D1 (de) VERFAHREN ZUR STEREOSELEKTIVEN HERSTELLUNG VON 8-g(a),12-OXIDO-13,14,15,16-TETRANORLABDAN.
ES2086065T3 (es) Preparacion de tetrahidropiridinas sustituidas.
DK0431759T3 (da) Fremgangsmåde til fremstilling af et ranitidinharpiksadsorbat
DE69009682D1 (de) Verfahren zur Herstellung von Cyclohexanolderivaten.
DK164628C (da) Fremgangsmaade til forbedring af ristet kaffe
DE69020119D1 (de) Verfahren zur Herstellung von hochreiner Naphthalin-2,6-Dicarbonsäure.
DE68923635D1 (de) Verfahren zur Herstellung von fester Lactulose.
JPS5659716A (en) Separating method of gamma-globulin aggregate with membrane
BE886438A (fr) Procede de preparation du glucoside de l'acide mycophenolique, et glucoside ainsi obtenu
DK0685492T3 (da) Fremgangsmåde til fremstilling af molekylært ensartede hyperpolymere hæmoglobiner
JPS56104866A (en) Production of (2r,4r)-4-alkyl-2-piperidinecarboxylic acid or its l-tartarate salt
DE69021442D1 (de) Verfahren zur Herstellung von 2, 3-Di-substituierten Cyclopentanonen.
ATE58519T1 (de) Herstellung von trichlorphenol.
DE68908843T2 (de) Verfahren zur Herstellung von 4,6-Dimethyl-7-hydroxynonan-3-on.
ATE8986T1 (de) Verfahren zur herstellung von formaldehyd.
ATE41141T1 (de) Verfahren zur herstellung von trichlorphenol.